Livemint Recent deaths in Gambia, Uzbekistan and the US, allegedly caused by toxic drugs made in India, has the Centre reportedly planning to centralize drug regulation. How effective will this measure be? The Central Drugs Standard Control Organization (CDSCO) is the apex regulatory body. Each state has its own regulator. The state regulators look after licencing and audit manufacturing facilities while CDSCO is responsible for approving new drugs, imports of devices, clinical...
More »SEARCH RESULT
Maiden pharma, under WHO scanner for Gambia kids' deaths, flouted norms in 4 states -Milan Sharma
-IndiaToday.in The Central Drugs Standard Control Organisation (CDSCO) has not yet barred the company from operations in India even as many of its medical products made for Indian use have also been found to be of substandard quality, often flagged by authorities. Ever since Maiden Pharmaceuticals has come under the scanner of the World Health Organisation (WHO) after being flagged for the four cough syrups manufactured in India and exported to Gambia...
More »Drugs board orders probe after WHO’s alert against India-made cough syrups -Sneha Mordani
-IndiaToday.in The Central Drugs Standard Control Organisation has launched a probe after the World Health Organisation (WHO) issued an alert against four India-made cough syrups. The Central Drugs Standard Control Organisation (CDSCO) has launched a probe after the World Health Organisation issued an alert against four India-made cold and cough syrups that have been "potentially linked" with acute kidney injuries and 66 deaths among children in the African country, The Gambia. According to...
More »Nobody approved India's 'Precautionary' doses -Banjot Kaur
-TheWire.in * Neither the CDSCO nor the national advisory group on immunisation was taken into confidence before Prime Minister Modi announced the rollout of booster doses. * In reply to a series of RTI applications by The Wire Science, the PMO and the health ministry refused to divulge details of the government’s decision-making. * One reply indicated that the government had misled the Supreme Court about the availability of the minutes of an...
More »Is the govt. doing enough for the Jan Aushadhi scheme?
On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...
More »